Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
99 studies found for:    Open Studies | "Adrenal Gland Diseases"
Show Display Options
Rank Status Study
1 Recruiting Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
Condition: Adrenal Disease
Interventions: Procedure: PRA;   Procedure: LA
2 Recruiting A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency
Condition: Chronic Adrenal Insufficiency
Intervention:
3 Recruiting Laparoscopic Adrenalectomy Versus Radiofrequency Ablation
Conditions: Hyperaldosteronism;   Conn Syndrome;   Adrenocortical Adenoma
Interventions: Procedure: Radiofrequency Ablation;   Procedure: Laparoscopic Adrenalectomy
4 Recruiting Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Conditions: Primary Adrenal Insufficiency;   Secondary Adrenal Insufficiency
Interventions: Drug: Plenadren;   Drug: Conventional glucocorticoid therapy
5 Recruiting UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Conditions: Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
Intervention: Biological: DUOC-01
6 Recruiting Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Intervention: Drug: R-roscovitine
7 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
8 Unknown  Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function
Condition: Cirrhosis With Ascites
Interventions: Drug: hydrocortisone;   Drug: dextrose solution 5%
9 Recruiting Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: SOM230 LAR 30 mg;   Drug: SOM230 LAR 10 mg
10 Recruiting An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide sub-cutaneous formulation
11 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:
12 Recruiting Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention:
13 Recruiting Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Interventions: Drug: Hydrocortisone;   Drug: Cortisone acetate
14 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
15 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
16 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Intervention: Procedure: Adrenalectomy
17 Unknown  Preoperative Bexarotene Treatment for Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Bexarotene
18 Recruiting HSCT for High Risk Inherited Inborn Errors
Conditions: Adrenoleukodystrophy;   Metachromatic Leukodystrophy;   Globoid Cell Leukodystrophy;   Tay Sachs Disease;   Sandhoffs Disease;   Wolman Disease;   I-Cell Disease;   Sanfilippo Syndrome;   GM1 Gangliosidosis
Interventions: Drug: Clofarabine;   Procedure: Total body Irradiation;   Drug: Melphalan;   Biological: Hematopoietic Stem Cell Transplantation;   Drug: Alemtuzumab;   Drug: mycophenylate mofetil;   Device: Cyclosporine A;   Drug: Hydroxyurea
19 Recruiting Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: Pasireotide;   Drug: Cabergoline
20 Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years